Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro.

Kawasaki, Daisuke

Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro. [electronic resource] - Cancer chemotherapy and pharmacology Apr 2008 - 883-92 p. digital

Publication Type: Journal Article

0344-5704

10.1007/s00280-007-0591-8 doi


Adenocarcinoma--drug therapy
Administration, Oral
Animals
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Benzodiazepinones--administration & dosage
Cell Line, Tumor
Cell Proliferation--drug effects
Deoxycytidine--administration & dosage
Disease Models, Animal
Female
Gastrins
Humans
Mice
Mice, Nude
Pancreatic Neoplasms--drug therapy
Phosphorylation--drug effects
Proto-Oncogene Proteins c-akt--drug effects
Receptor, Cholecystokinin B--antagonists & inhibitors
Survival Rate
Xenograft Model Antitumor Assays
Gemcitabine